Skip to main content

Articles

FDA Approvals
FDA Approves Durvalumab in Combination With Bacillus Calmette-Guérin for High-Risk Non–Muscle Invasive Bladder Cancer
Read More
FDA Approvals
FDA Grants Accelerated Approval to Zongertinib for HER2-Mutated NSCLC
Read More
FDA Approvals
FDA Grants Approval to Encorafenib for BRAF V600E–Mutated Metastatic Colorectal Cancer
Read More
FDA Approvals
FDA Approves Teclistamab Combination Therapy for Relapsed or Refractory Multiple Myeloma
Read More
Online Only
FDA Approvals
FDA Approves Darzalex Faspro-VRd Combination for Newly Diagnosed Multiple Myeloma Patients Ineligible for Transplant
Read More
Online Only
FDA Approvals
New Treatment Option for Platinum-Resistant Ovarian Cancer Patients
Read More
Online Only
Original Research, Acute Lymphoblastic Leukemia, Anticoagulants, Thromboembolism
Evaluation of Clotting and Bleeding Risk Associated With the Use of Asparaginase Drugs in Patients With Acute Lymphoblastic Leukemia
Alyssa Cendagorta, PharmD, BCOP; Frank Lattuca, PharmD, BCOP; Jeremiah E. Moore, PharmD, BCOP; Kristen O’Dwyer, MD; Andrea Baran, MS; Nicole M. Acquisto, PharmD, FASHP, FCCM, FCCP, BCCCP; Carissa Treptow, PharmD, BCOP
Read More
FDA Approvals
FDA Approves Optune Pax: A Breakthrough Treatment for Locally Advanced Pancreatic Cancer
Read More
Online Only
Immunotherapy
Immunotherapy Helps Navy Veteran Beat Stage 4 Lung Cancer
Read More
Online First
Biomarkers
Gaps in Biomarker Testing and Targeted Therapy for Gastric Cancer
Read More
Page 1 of 244
Results 1 - 10 of 2440